Annual Grant Award Dollars
| Investigator | Title | Sponsor | ID | Dates | Amount |
| MD, MS Theresa Guilbert | Controlling and preventing Asthma progression and Severity in Kids (CASK) | The Children's Hospital Corp d/b/a Boston Children's Hospital | NIH | 7/1/2017-6/30/2021 | $512,708 |
| Alister J Bates | Improving Outcomes in Pediatric Obstructive Sleep Apnea with Computational Fluid Dynamics | National Heart, Lung & Blood Institute National Institues of Health (NIH) | K99HL144822 | 9/1/2020-8/31/2021 | $156,956 |
| Anjaparavanda Naren, PhD | Transporters and Hematopoietic Toxicity | St Jude's Children's Hospital (National Cancer Institute)National Institues of Health (NIH) | R01CA194206 | 7/1/2020-6/30/2021 | $28,595 |
| Anjaparavanda Naren, PhD | Inhibition of an Apical cAMP/cGMP Transporter(MRP4)in the Gut Induces Diarrhea | Ntl Inst of Diab & Digest & Kidney Dis National Institues of Health (NIH) | R01DK080834 | 6/1/2020-5/31/2022 | $721,036 |
| Anjaparavanda Naren, PhD | CCHMC RDP Personalizing Cystic Fibrosis Research Translation | Cystic Fibrosis Foundation | Naren19R0 | 7/1/2020-6/30/2021 | $600,000 |
| Anjaparavanda Naren, PhD | Investigating of the Mechanisms of Action of CFTR Correctors in Rescuing Delta F508-CFTR | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL147351 | 7/1/2020-6/30/2021 | $422,302 |
| Anjaparavanda Naren, PhD John Clancy, MD Jeffrey A Whitsett, MD |
Personalized Cystic Fibrosis Therapy and Research Center | Ntl Inst of Diab & Digest & Kidney Dis National Institues of Health (NIH) | P30DK117467 | 7/1/2020-6/30/2021 | $772,058.67 |
| Assem Ziady, PhD | Longitudinal Study of Cystic Fibrosis Liver Disease | University of Colorado (Cystic Fibrosis Foundation ) | NARKEW16AB0 | 1/1/2019-12/31/2019 | $11,764 |
| Assem Ziady, PhD | Predictive Molecular Markers of Lung Function Decline | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL142210 | 4/1/2020-3/31/2022 | $872,146 |
| Assem Ziady, PhD Rhonda Szczesniak, PhD |
Commercial Translation of Biomarker-based Platform for Personalized Forecasting of Rapid Lung Function Decline | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R61HL154105 | 9/1/2020-7/31/2021 | $195,622 |
| Carolyn Dress, MD | First and Second Year Clinical Fellowship | Cystic Fibrosis Foundation | DRESS20B0 | 7/1/2020-6/30/2021 | $62,000 |
| Christopher Siracusa, MD | DESIGN CF: Developing e-Health Systems to Improve Growth and Nutrition in CF (PhaseII) | Children's Hospital Boston (Cystic Fibrosis Foundation ) | CHB;Siracusa | 1/1/2020-12/31/2020 | $29,168 |
| Christopher Siracusa, MD | Qualitative Understanding of Experiences with the SIMPLIFY Trial (QUEST) | Children's Hospital Boston (Cystic Fibrosis Foundation ) | STRC-113-20-01 | 9/1/2020-8/31/2021 | $6,348 |
| Christopher Siracusa, MD | Success with Therapies Research Consortium Award | Cystic Fibrosis Foundation | SIRACU15PEO | 8/1/2020-7/31/2021 | $34,720 |
| Christopher Siracusa, MD | CTA Qualitative Understanding of Experiences with the SIMPLIFY Trial (QUEST) | Children's Hospital Boston (Cystic Fibrosis Foundation ) | STRC-113-20-01 | 9/1/2020-3/31/2023 | $3,360 |
| Daniel A Ignatiuk, MD | Aspire ATS Fellowship | American Thoracic Society | ATS_ASPIRE | 7/1/2020-6/30/2021 | $10,000 |
| Duncan E Keegan, MD | First and Second Year Clinical Fellowship | Cystic Fibrosis Foundation | KEEGAN19B0 | 7/1/2020-6/30/2021 | $66,750 |
| Elizabeth L Kramer, MD, PhD | TGF-Beta Regulates CFTR-Mediated Airway Smooth Muscle Dysfunction | National Heart, Lung & Blood Institute National Institues of Health (NIH) | KHL151762A | 2/1/2021-1/31/2022 | $164,160 |
| Gary McPhail, MD | A master protocol to test the impact of discontinuing chronic therapies in people with cystic fibrosis on highly effective CFTR modulator therapy (SIMPLIFY) | Seattle Children's (Cystic Fibrosis Foundation ) | Seattle Ch - McPhail | 9/10/2020-3/9/2023 | $112,035 |
| Gary McPhail, MD | Improving P. aeruginosa Detection in Non-expectorators via Breath Testing | University of British Columbia (Cystic Fibrosis Foundation ) | HILL18A0-CI | 4/1/2020-3/31/2021 | $13,386 |
| Gary McPhail, MD | Improving P. aeruginosa Detection in Non-expectorators via Breath Testing | University of British Columbia (Cystic Fibrosis Foundation ) | HILL18A0-CI | 4/1/2020-3/31/2021 | $16,164 |
| Gary McPhail, MD | A Prospective Study to Evaluate Biological and Clinical Effects of Segnificantly Corrected CFTR Function in Infants and Your Children (BEGIN) | Seattle Children's (Cystic Fibrosis Foundation ) | Seattle Childrens-CF | 4/29/2021-4/28/2025 | $102,583 |
| Gary McPhail, MD Anil Goud Jegga DVM Anjaparavanda Naren, PhD |
Preclinical Characterization of Saracatinib for Cystic Fibrosis Therapy | Natl. Ctr for Advancing Translational Sc National Institues of Health (NIH) | UG3 TR002612 | 9/1/2020-8/31/2021 | $238,500.67 |
| Jason C Woods, PhD | MRI Phenotyping of Early BPD and Prediction of Outcomes | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL146689 | 4/1/2021-3/31/2022 | $757,550 |
| Jason C Woods, PhD | Hyperpolarized Imaging for New Therapies (HyPOINT) in Pediatric CF | Cystic Fibrosis Foundation | CFF Woods | 8/1/2020-7/31/2021 | $732,050 |
| John J Brewington, MD | Personalized Model Systems to Predict and Investigate CFTR Drug Response in CF | National Heart, Lung & Blood Institute National Institues of Health (NIH) | K08HL144825 | 8/1/2020-7/31/2021 | $163,620 |
| John J Brewington, MD | K Supplement Personalized Model Systems to Predict/Investigate CFTR Drug Response in CF | Cystic Fibrosis Foundation | CFF_Brewington | 8/1/2020-7/31/2021 | $50,000 |
| John J Brewington, MD | Nasal Cell Theratyping Advancement Core | Cystic Fibrosis Foundation | CFF_Brewington_Outco | 4/1/2020-3/31/2021 | $168,000 |
| John J Brewington, MD | Understanding CF lung Infections That Persist After Trikaftaewington: UW-Dr. Singh | University of Washington (Cystic Fibrosis Foundation ) | UWSC12031/SINGH19K0 | 11/1/2019-10/31/2021 | $102,906 |
| KYU SHIK MUN | Patient-derived Pancreatic Duct-on-a-chip to study CFTR Channel Function | Cystic Fibrosis Foundation | Mun CFF Fellowship | 4/1/2020-3/31/2021 | $67,800 |
| Michael Seid, PhD | CF Learning Network: Implementation Phase | Cystic Fibrosis Foundation | SEID19AB0 | 1/1/2021-12/31/2021 | $2,382,241 |
| Nara S Higano, PhD | Quantitative MRI of pulmonary ventilation patterns in preterm infants with correlation to respiratory outcomes | Little Giraffe Foundation | Little Giraffe_Higan | 10/1/2020-3/31/2022 | $9,000 |
| Neil Stewart | Rapid, Multi-Functional MRI for Infant Lung Disease | Thrasher Research Fund | Thrasher_Stewart | 1/1/2021-12/31/2021 | $13,375 |
| Pramodha S Liyanage | Insights into CFTR Conformational Dynamics Using smFRET in Real-Time | Cystic Fibrosis Foundation | LIYANA19F0 | 5/1/2020-10/31/2021 | $99,475 |
| Raouf Samy Amin, MD | Impact of Treatment of Mild Sleep-Disordered Breathing o | Children's Hospital of Philadelphia (National Heart, Lung & Blood Institute)National Institues of Health (NIH) | U01HL125295 | 7/1/2019-6/30/2020 | $153,826 |
| Raouf Samy Amin, MD | Pulmonary Vascular Disease in Cystic Fibrosis | Cystic Fibrosis Foundation | AMIN19A0 | 1/1/2021-12/31/2021 | $371,260 |
| Raouf Samy Amin, MD | CF Center Accreditation and CF Center Awards | Cystic Fibrosis Foundation | 000734CC320 | 7/1/2020-6/30/2021 | $194,340 |
| Satish K Madala, PhD | WT1 Regulation of Pulmonary Fibrosis | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL134801 | 5/1/2020-4/30/2021 | $389,917 |
| Theresa Guilbert, MD, MS | ORBEX: Primary Prevention of Asthma and Wheezing in Chil | University of Arizona (National Heart, Lung & Blood Institute)National Institues of Health (NIH) | PO 438886 | 5/1/2020-4/30/2021 | $186,563 |
| Theresa Guilbert, MD, MS | ORBEX CTA: Primary Prevention of Asthma and Wheezing in Chil | University of Arizona (National Heart, Lung & Blood Institute)National Institues of Health (NIH) | PO 438886 | 5/1/2020-4/30/2021 | $279,247 |
| William D Hardie, MD | Cincinnati Children's Summer Medical Student Respiratory Research Fellowship | National Heart, Lung & Blood Institute National Institues of Health (NIH) | THL113229C | 5/1/2021-4/30/2022 | $82,701 |
| William D Hardie, MD John Clancy, MD |
Cincinnati Children's Summer Medical Student Respiratory | National Heart, Lung & Blood Institute National Institues of Health (NIH) | T35HL113229 | 5/1/2020-4/30/2021 | $71,920 |
| Yunjie Huang, PhD | Targeting Novel ER Lumical ER-QC to Rescue Mutant CFTR | Cystic Fibrosis Foundation | HUANG20F5 | 5/1/2020-4/30/2022 | $154,190 |
| Zackary Cleveland, PhD | Validating Quantitative Magnetic Resonance Imaging Biomarkers of Idiopathic Pulmonary Fibrosis | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL143011 | 1/1/2021-12/31/2021 | $688,240 |
| Zackary Cleveland, PhD Assem Ziady, PhD |
Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease | National Heart, Lung & Blood Institute National Institues of Health (NIH) | RHL151588A | 2/3/2021-1/31/2022 | $729,164 |
| Total Annual Grant Award Dollars | $12,999,747.34 | ||||
Annual Industry Award Dollars
| Investigator | Industry Sponsor | Amount |
| Alister J Bates | Inspire Medical Systems, Inc | $65,000 |
| Kavisha Arora, PhD | Gilead Sciences, Inc. | $65,000 |
| Narong Simakajornboon, MD | Pulse Infoframe US, LLC | $5,500 |
| Sheharyar Durrani, MD | Astrazeneca | $51,342 |
| Total Annual Industry Award Dollars | $186,842 | |
